Literature DB >> 422244

Experimental sporotrichosis in Syrian hamsters.

Y Charoenvit, R L Taylor.   

Abstract

Syrian hamsters were infected with Sporothrix schenckii by subcutaneous footpad inoculation. Two types of infection could be uniformly induced: a self-limited, lymphatic infection resembling the classical disease in humans, and a generalized nonfatal infection. An infecting dose of approximately 5,300 yeast cells produced the localized subcutaneous-lymphatic disease which was limited to a single limb. In contrast, a 1,000-fold increase in the inoculum temporarily overwhelmed the animals' defense mechanisms, producing a systemic infection involving the liver and spleen. These models were used to demonstrate the development of increased resistance to subsequent infection following either infection or active immunization with ribosomal fractions or trypsinized cell wall antigens of S. schenckii incorporated in Freund complete adjuvant. Agglutination titers were detectable in all animals that were either infected or immunized. In one group of infected animals, the titers persisted for at least 1 year after three booster doses of Formalin-killed S. schenckii. The ability to produce an infection in hamsters which closely resembles the disease seen in humans makes the animal a good model with which to study experimental sporotrichosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422244      PMCID: PMC414174          DOI: 10.1128/iai.23.2.366-372.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Attempts to immunize mice against sporotrichosis.

Authors:  H F HASENCLEVER; W MITCHELL
Journal:  J Invest Dermatol       Date:  1959-09       Impact factor: 8.551

2.  Sporotrichosis; report of a case.

Authors:  C L LIU
Journal:  Chin Med J       Date:  1955 Jul-Aug

3.  [Experimental sporotrichosis of the hamster; observation of asteroid forms of Sporotrichum].

Authors:  F MARIAT; E DROUHET
Journal:  Ann Inst Pasteur (Paris)       Date:  1954-04

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Sporotrichosis; clinical and laboratory features and a serologic study in experimental animals and humans.

Authors:  A NORDEN
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1951

6.  Experimental sporotrichosis in the normal and modified host.

Authors:  K K Sethi
Journal:  Sabouraudia       Date:  1972-03

7.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

8.  Experimental cutaneous sporotrichosis.

Authors:  K K Sethi; J Schwarz
Journal:  Mykosen       Date:  1965-10-01

9.  Serologic aspects of sporotrichosis.

Authors:  J V Karlin; H S Nielsen
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

10.  EFFECT OF MITOCHONDRIAL STABILIZERS ON THE IMMUNOGENICITY OF THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-06       Impact factor: 3.490

View more
  6 in total

Review 1.  Sporothrix schenckii and related species of Ceratocystis.

Authors:  L R Travassos; K O Lloyd
Journal:  Microbiol Rev       Date:  1980-12

2.  A case of sporotrichosis caused by two genetically different Sporothrix schenckii strains.

Authors:  H Kobayashi; M Kawasaki; H Ishizaki; R Fukushiro; R Matsumoto
Journal:  Mycopathologia       Date:  1990-10       Impact factor: 2.574

3.  Keratinocyte Response to Infection with Sporothrix schenckii.

Authors:  Araceli Paredes-Rojas; Alejandro Palma-Ramos; Laura Estela Castrillón-Rivera; Felipe Mendoza-Pérez; María Del Carmen Navarro-González; Roberto Arenas-Guzmán; Jorge Ismael Castañeda-Sánchez; Julieta Luna-Herrera
Journal:  J Fungi (Basel)       Date:  2022-04-23

4.  What lies beyond genetic diversity in Sporothrix schenckii species complex?: New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates.

Authors:  Orazio Romeo; Giuseppe Criseo
Journal:  Virulence       Date:  2013-01-18       Impact factor: 5.882

Review 5.  Overview of vertebrate animal models of fungal infection.

Authors:  Tobias M Hohl
Journal:  J Immunol Methods       Date:  2014-04-04       Impact factor: 2.303

6.  Immunization with recombinant enolase of Sporothrix spp. (rSsEno) confers effective protection against sporotrichosis in mice.

Authors:  Deivys Leandro Portuondo; Paulo Roberto Dores-Silva; Lucas Souza Ferreira; Carlos S de Oliveira; Damiana Téllez-Martínez; Caroline Maria Marcos; Maria Luiza de Aguiar Loesch; Fanny Guzmán; Lisandra M Gava; Júlio César Borges; Sandro Antonio Pereira; Alexander Batista-Duharte; Iracilda Zeppone Carlos
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.